Amid escalating climate concerns and the pursuit of sustainable business operations, Sandoz has entered into a notable partnership with Elawan Energy. The duo plans to develop solar projects in Spain with an installed capacity of 150 MW. This ambitious undertaking is set to power a significant portion of Sandoz’s operations across Europe. With a firm target of achieving net zero emissions by 2050, Sandoz aims to transition its European operations to be predominantly powered by renewable energy sources. The deal aligns with their long-term sustainability strategy by supplying nearly 90% of their electricity needs in the region.
In previous agreements, companies have often focused on short-term goals, but this 10-year Power Purchase Agreement (PPA) between Sandoz and Elawan Energy deviates by committing to a longer renewable energy strategy. Past endeavors by pharmaceutical firms have included various renewable projects, yet the scale and duration of this new alliance highlight an elevated commitment. Unlike previous endeavors, the current focus provides Sandoz with a clearer path to fulfilling international sustainability commitments.
How Will the Elawan Partnership Impact Sandoz?
With the new solar framework with Elawan, Sandoz is setting its sights on dramatically reducing its carbon emissions in Europe. The eventual aim of meeting 90% of its electricity demand in the region signifies a meaningful cut in greenhouse gas emissions. As these solar projects come to fruition, they are set to operate at efficiency levels, gradually phasing out reliance on fossil fuels. The collaboration underlines Sandoz’s strategy to meet the ambitious carbon reduction targets it has pledged to the Science Based Targets initiative (SBTi) within upcoming years.
What Does This Mean for Elawan Energy?
For Elawan Energy, this partnership facilitates the growth of crucial projects in their development portfolio. “We are proud to partner with Sandoz, the global leader in generic and biosimilar medicines, in this corporate PPA,” declared Diego Garcia, head of Revenue Management and PPAs at Elawan. This collaboration enhances their visibility and reinforces their core mission of catalyzing the shift toward renewable energy use on a broader scale.
The projects are slated for development in Castilla y León, a region within Spain noted for its solar potential. The successful implementation of these projects is expected to bolster Elawan Energy’s standing in the energy market, facilitating further developments and potential partnerships. Sandoz also anticipates benefiting from cost efficiency as it enhances its energy procurement strategy.
Sandoz’s previous corporate sustainability strategies have emphasized incremental growth in clean energy investments. However, unlike prior efforts that stated targets, the Elawan project gives tangible progress in achieving substantial electricity coverage. Glenn Gerecke, Sandoz’s Chief Manufacturing and Supply Officer, noted, “Our collaboration with Elawan Energy to develop this new solar project in Spain marks a concrete step toward decarbonizing our operations. By covering nearly 90% of electricity demand for our current European operations, we will reduce our environmental footprint and advance our commitment to a more sustainable future.”
Through their commitment to the development of solar energy, both Sandoz and Elawan Energy venture into a mutual benefice, showcasing firm dedication to sustainability goals. Sandoz’s proactive approach in meeting an extensive portion of its power needs through solar platforms epitomizes a broader shift in industrial energy strategies. This project establishes a strong precedent for the pharmaceutical sector, emphasizing the integration of sustainable practices without compromising operational effectiveness.
